Is there published peer-reviewed clinical literature specifically on "Ozempic feet"
But a shortage, which opened the door to cheaper, off-brand alternatives, along with growing competition from Eli Lilly, maker of the rival diabetes drug Mounjaro, sent Novo Nordisk shares sliding last year
Appetite suppression and improved food control can be significant benefits, but nausea, constipation, reflux, and fatigue can occur, especially during dose increases
To learn more about this emerging area of research, watch the full video and explore more topics on the UCI MIND YouTube channel, UCI MINDCast
What makes the biggest difference is staying in communication with your doctor or pharmacist
Every mybest article is crafted with hours of in-depth research and interviews with experts